Funder
Prince Sattam bin Abdulaziz University
Subject
Spectroscopy,Instrumentation,Atomic and Molecular Physics, and Optics,Analytical Chemistry
Reference38 articles.
1. National Center for Biotechnology Information. PubChem Compound Summary for CID 46188928, Larotrectinib. https://pubchem.ncbi.nlm.nih.gov/compound/Larotrectinib. Accessed Sept. 9, 2022.
2. Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor for the treatment of TRK fusion cancer;Federman;Expert Rev. Clin. Pharmacol.,2019
3. A dried blood spot assay with HPLC–MS/MS for the determination of larotrectinib in mouse blood and its application to a pharmacokinetic study;Tripathy;Biomed. Chromatogr.,2020
4. Metabolic stability assessment of larotrectinib using liquid chromatography tandem mass spectrometry;Attwa;Drug Des. Dev. Ther.,2020
5. Identification and characterization of unknown degradation product of larotrectinib sulphate;Kavitapu;Mater. Today,2021
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献